Join
Live feed
·
INSIDERFilingvia Quantisnow
Foghorn Therapeutics Inc. logo

Chief Scientific Officer Bellon Steven F. sold $190,000 worth of shares (20,000 units at $9.50), decreasing direct ownership by 16% to 101,957 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
FHTX· Foghorn Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FHTX (Foghorn Therapeutics Inc.) and more on Quantisnow.